Subscribers,

Pardon the interruption once again, but our trade idea SNWV just announced some news this morning that I have to share with you...

SANUWAVE Health Enters the Carolinas, Hires Key Representative and Will Participate in the Modern Wound Care Management Conference April 26-27 in Greensboro, NC

Suwanee, GA, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (SNWV) ( www.sanuwave.com) announced they have entered North and South Carolina as their 5th and 6th markets in 2019, also hiring David Cummings to lead SANUWAVE in the Carolinas.  SANUWAVE is excited to execute on their commercialization plan to enter into 6 states in 2019 by adding the Carolinas.  David joins SANUWAVE from Integra and previously Derma Science, which was acquired by Integra in 2017.  Mr. Cummings will participate and help SANUWAVE launch the dermaPACE System in the Carolinas this weekend.  

SANUWAVE Health, Inc. is an emerging regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. 

SANUWAVE is proud to be a sponsor for the Modern Wound Care Management (MWCM) meeting taking place April 26-27, 2019 in Greensboro, NC.  The MWCM mission is to provide the highest quality continuing education experience to all clinicians who care for patients with chronic wounds.  This event is a true interdisciplinary approach to wound care with input from multiple specialties.  It is designed for more proactive audience participation and interaction with national experts in wound care, including physicians, podiatrists, nurses, physical therapists and other wound care modality providers.

David has been a Carolina resident for decades.  President, Shri Parikh, comments, “David’s work in wound care, and the diabetic population, helped him significantly contribute to Derma Science’s rapid growth prior to being acquired by Integra. David’s work in DFU treatment as an expert in Total Contact Casting gives him a great deal of credibility among wound care professionals.   David supported this clinical and market growth as an individual contributor, trainer and leader during his eleven-year tenure.  We are excited to have him join our team and confident he’ll deliver equally impressive results.” 

“We began 2019 with the objective of placing 100 devices.  To achieve this, we are focusing on 6 states which cover 33% of the US population.  These states were chosen based on three criteria: population density of diabetics, favorable insurance environments for new products and devices, and the ability of SANUWAVE to support and educate the commercialization roll out plan.  By entering the Carolinas we have now entered all six states for 2019 and will now begin to place devices rapidly and educating and certifying our clinical users.   As usage increases in these states we should begin to experience a positive reimbursement environment due to the strong benefits the device brings to treating DFU’s,” said Kevin Richardson, CEO.

Read press release in full at https://finance.yahoo.com/news/sanuwave-health-enters-carolinas-hires-123000419.html


-----------------------------------------------------------------------------------------


We introduced you to SNWV last night. It was setting our scanners alight yesterday and we think today could be even better.

Get SANUWAVE Health, Inc (SNWV) on your screen immediately.

SNWV made a monster move in the market yesterday, jumping almost 15% on massive volume, bouncing perfectly off long term support.

And with the major news the Company announced yesterday, it could be the start of an even bigger longer term move.

The Company announced on Monday that it will present at the Planet MicroCap Showcase at on Wednesday, May 1, 2019 and will conduct 1on1 meetings on May 2, 2019.


SNWV is a little known company is “U.S. FDA cleared” for treating a significant global problem that afflicts many individuals.

You might not realize it but open wounds (ulcers) can be a life threatening condition for many people. 

For people with diabetes, for example, certain parts of their body may receive poor circulation of blood flow, which limits the ulcers ability to heal.

In fact, “these ulcers are responsible for more than 80.0% of all diabetes-related lower-leg amputations and occur in around 15.0% of diabetic patients.”

According to the CDC, “more than 100 million U.S. adults are now living with diabetes or prediabetes”.

But there might be hope for those afflicted by this condition.


About SNWV...

SNWV is a shock wave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.

SANUWAVE's portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new vascularization and microcirculatory improvement, which helps restore the body's normal healing processes and regeneration.

SANUWAVE applies its patented PACE® technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Its lead product candidate for the global wound care market, dermaPACE®, is US FDA cleared for the treatment of Diabetic Foot Ulcers.

The device is also CE Marked throughout Europe and has device license approval for the treatment of the skin and subcutaneous soft tissue in Canada, South Korea, Australia and New Zealand. SANUWAVE researches, designs, manufactures, markets and services its products worldwide, and believes it has demonstrated that its technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) through its U.S. Class III PMA approved OssaTron® device, as well as stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment through the utilization of its OssaTron, Evotron® and orthoPACE® devices in Europe, Asia and Asia/Pacific.

In addition, there are license/partnership opportunities for SANUWAVE's shock wave technology for non-medical uses, including energy, water, food and industrial markets.

SANUWAVE Health, Inc. is an emerging regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures.

You can learn more about SNWV at their website http://www.sanuwave.com/template_files/946/home.php

The Company recently updated the market on its International Registrations, attendance at trade shows and ISO certifications.

Regulatory Status World-Wide

As mentioned above, SANUWAVE has received U.S. FDA clearance for the sales, distribution, and marketing of the company’s flagship medical device, dermaPACE® System for the treatment of Diabetic Foot Ulcers (DFUs).  While the U.S. clearance is recent, SANUWAVE has maintained a strong and visible presence in several, major international medical device markets. 

These include the company’s CE Marking for the European Union for both the dermaPACE® System for wound care and orthoPACE® System for treating orthopedic conditions, with a primary concentration in Italy, Belgium, The Netherlands, Luxembourg, Spain, Portugal, Romania, and Bulgaria.  SANUWAVE has medical device licensing in Canada for dermaPACE® System as well as medical device licensing in Australia and New Zealand, also for dermaPACE® System.  South Korea remains a strong market for the orthoPACE® System for various orthopedic conditions. 

Most recently, medical device licensing was obtained for orthoPACE® System in Taiwan.  Licensing for dermaPACE® System has also recently been obtained for Malaysia.  The ability to distribute in the Philippines has recently been made available.

In addition to countries in which SANUWAVE is making its presence known, we expect to expand this list with 3 – 4 more registrations in 2019.  We are actively engaged in the registration and licensing process in Asia with Indonesia, Singapore, and Taiwan (for dermaPACE®).  Closer to home, SANUWAVE is working on licensing in Mexico, Costa Rica, Panama, and Brazil.  These processes are time-consuming, and we are anticipating successful completion to most, but not all, of these market applications.

Upcoming Attendance at Major Medical Shows and Conferences

Upcoming shows at which SANUWAVE will have a major presence include:

·         Modern Wound Care Management, Greensboro, NC (April 26 -27, 2019)
·         Symposium of Advanced Care (SAWC) Spring, San Antonio, TX (May 7 – 11, 2019)
·         International Symposium on the Diabetic Foot (ISDF), The Hague, The Netherlands (May 22 – 25, 2019)
·         European Wound Management Association (EWMA), Gothenburg, Sweden (June 5 – 7, 2019)
·         “The National” American Podiatric Medical Association (APMA), Salt Lake City, UT (July 11 -14, 2019)

SANUWAVE Quality System

As part of our ongoing efforts to ensure that the products and services which SANUWAVE provides to its customers are aligned with our Mission, Vision, Quality Policy, and Regulatory Requirements, we are pleased to announce that SANUWAVE has successfully completed the transition of our Quality Management System (QMS) from ISO 13485:2003 to the current revision ISO 13485:2016.

The British Standard Institution (BSI) performed the audit of SANUWAVE’s QMS on February 26 – 27, 2019 and upon completion of the audit has recommended the company for certification. ISO 13485:2016 is the Medical Devices – Quality Management Systems – Requirements for regulatory purposes. Organizations that design, manufacture, install and service medical devices seek to obtain the voluntary ISO 13485 certification to demonstrate to regulatory agencies like the U.S. FDA, Health Canada, the European Commission, and others that they are committed to operating under a defined Quality Management System.

You can read more recent news on SNWV at https://finance.yahoo.com/quote/SNWV?p=SNWV&.tsrc=fin-srch

Our Conclusion...

SNWV had a monster day yesterday after it rose 15% on strong volume with a major catalyst behind it. We think this could be the start of a longer term move higher.

Now could be the perfect time to jump on board.

All the best.

SmallCapMomo.com

picks@smallcapmomo.com

Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.